• 2001 anthrax attacks chief suspect kills himself

    Bruce Ivins, the FBI’s chief suspect in the 2001 anthrax attacks — after the previous main suspect, Steven Hatfill, has been exonerated — commits suicide; scientist kills himself after being told that the government was about to file criminal charges against him

  • Calgary researcher wins NIH grant for bacterial vaccine

    CDC considers glanders and melioidosis as potential bioterrorism agents; Canadian researcher receives NIH grant to develop a vaccine

  • Bioterrorism rule ineffective in salmonella outbreak

    Rules and regulations passed in the wake of 9/11 were supposed to tighten monitoring and tracking food items, so an outbreak of food-borne illness could be quickly traced to its source; food supply-chain practices make these rules and regulations difficult to implement

  • Is the U.S. prepared for a bioterror attack?

    Some experts believe a bioterrorist attack or pandemic outbreak could be inevitable. How would the United States fight back against an infectious disease outbreak?

  • Bioterrorism target for ventilation research

    Designing new HVAC systems for buildings would help tackle major threats to public safety including the release of noxious chemicals and bio-agents into public buildings

  • New biological, chemical decontamination solution

    An airborne and surface decontamination system delivers a decontaminant mist that results in rapid surface area contact and full non-line-of-sight coverage

  • Worries about CDC pathogen handling

    In a new $214 million infectious disease laboratory at the Center for Disease Control and Prevention in Atlanta, scientists are conducting experiments on bioterror bacteria in a room with a containment door sealed with duct tape

  • Environmental report on new Biolab

    Following a GAO report which criticized how DHS decided on how research into contagious foreign animal and zoonotic diseases should be conducted, the Science and Technology Directorate of DHS issues a draft environmental impact statement and risk analysis for the six locations being considered for the new Biolab

  • Investing in biodefense companies, II

    Billions of dollars are being spent on finding vaccines and treatments for possible bioterror attacks; investment analyst says that these billions of dollars in government spending notwithstanding, when considering an investment in a company doing R&D in the bioterror field, you should consider its non-terror-related biotechnology efforts, and the quality of its management team

  • Good results in tests for BioNeutral's anti-anthrax technology

    New Jersey company uses its Ygiene formulation to kill anthrax spores on contact; formulation killed all anthrax spores exposed to the formulation in as little fifteen seconds

  • Universal biosensor would detect disease, bioterror attack, pollution

    A consortium of U.K. research institutions, in collaboration with a Chinese University, work on developing a universal biosensor which would help in many types of detection — from home diagnosis of disease to chemical plant monitoring, anti-bioterrorism, and pandemic outbreak

  • India to test anthrax vaccine

    India is worried about bioterror attacks by Islamic extremists; it starts testing the potency of U.S.-manufactured vaccine; initially enough doses will be stored to protect military personnel

  • Investing in biodefense companies

    Billions of dollars are pouring into biodefense vaccines and treatments; do companies engaged in developing such vaccines and treatment offer attractive investment opportunities? The answer is a qualified “Yes” to this specific question — but a more resounding “Yes” when these companies’ other research and development endeavors are taken into consideration

  • Tom Daschle calls for greater U.S.-U.K. bioterror cooperation

    Daschle: “The threat of bioterrorism will increase exponentially because biological agents used to carry out such attacks will continue to become more accessible and more technologically advanced”

  • OSHA issues guidance regarding storage of face masks, respirators

    OSHA requests comments on proposed guidance on workplace stockpiling of respirators and face masks for pandemic influenza